2017 Vol.35, N°3 - Table of contents
May-June 2017
Editorial
CER10590
2017,35,3
Pg. 0359-0361
Free to view
Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: time ready for a paradigm shift?
T. Alexander, F. Hiepe
T. Alexander, F. Hiepe
One year in review
CER10236
2017,35,3
Pg. 0362-0367
Free to view
One year in review 2017: ultrasound in crystal arthritis
E. Naredo, A. Iagnocco
E. Naredo, A. Iagnocco
CER10537
2017,35,3
Pg. 0368-0378
Free to view
One year in review 2017: pathogenesis of rheumatoid arthritis
F. Angelotti, A. Parma, G. Cafaro, R. Capecchi, A. Alunno, I. Puxeddu
F. Angelotti, A. Parma, G. Cafaro, R. Capecchi, A. Alunno, I. Puxeddu
Full Papers
CER9321
2017,35,3
Pg. 0379-0383
Free to view
The effects of an educational meeting and subsequent computer reminders on the ordering of laboratory tests by rheumatologists: an interrupted time series analysis
N. Lesuis, N. Den Broeder, N. Boers, E. Piek, S. Teerenstra, M. Hulscher, R. Van Vollenhoven, A.A. Den Broeder
N. Lesuis, N. Den Broeder, N. Boers, E. Piek, S. Teerenstra, M. Hulscher, R. Van Vollenhoven, A.A. Den Broeder
CER9681
2017,35,3
Pg. 0384-0389
Free to view
Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baseline
C. Krause, G. Herborn, J. Braun, H. Rudolf, S. Wassenberg, R. Rau, D. Krause
C. Krause, G. Herborn, J. Braun, H. Rudolf, S. Wassenberg, R. Rau, D. Krause
CER9634
2017,35,3
Pg. 0390-0400
Free to view
Efficacy and safety of tofacitinib in older and younger patients with rheumatoid arthritis
J.R. Curtis, H. Schulze-Koops, L. Takiya, C.A. Mebus, K.K. Terry, P. Biswas, T.V. Jones
J.R. Curtis, H. Schulze-Koops, L. Takiya, C.A. Mebus, K.K. Terry, P. Biswas, T.V. Jones
CER9692
2017,35,3
Pg. 0401-0405
Free to view
In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: comparison of two cohorts treated according to different treat-to-target protocols
S. Balduzzi, C.A. Scirè, G. Sakellariou, F. Benaglio, S. Bugatti, C. Montecucco, R. Caporali
S. Balduzzi, C.A. Scirè, G. Sakellariou, F. Benaglio, S. Bugatti, C. Montecucco, R. Caporali
CER9708
2017,35,3
Pg. 0406-0414
Free to view
Response of human rheumatoid arthritis osteoblasts and osteoclasts to adiponectin
G. Krumbholz, S. Junker, F.M. Meier, M. Rickert, J. Steinmeyer, S. Rehart, U. Lange, K.W. Frommer, G. Schett, U. Müller-Ladner, E. Neumann
G. Krumbholz, S. Junker, F.M. Meier, M. Rickert, J. Steinmeyer, S. Rehart, U. Lange, K.W. Frommer, G. Schett, U. Müller-Ladner, E. Neumann
CER9759
2017,35,3
Pg. 0415-0422
Free to view
Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis
K.Y. Kang, J.-Y. Jung, Y.S. Hong, J.H. Ju, S.-H. Park
K.Y. Kang, J.-Y. Jung, Y.S. Hong, J.H. Ju, S.-H. Park
CER9778
2017,35,3
Pg. 0423-0430
Free to view
Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study
J. Calvo-Alén, I. Monteagudo, G. Salvador, T.R. Vázquez-Rodríguez, J.V. Tovar-Beltrán, P. Vela, F. Maceiras, S. Bustabad, J.A. Román-Ivorra, C. Díaz-Miguel, J. Rosas, E. Raya, L. Carmona, L. Cea-Calvo, M.J. Arteaga, S. Fernández, C. Marras
J. Calvo-Alén, I. Monteagudo, G. Salvador, T.R. Vázquez-Rodríguez, J.V. Tovar-Beltrán, P. Vela, F. Maceiras, S. Bustabad, J.A. Román-Ivorra, C. Díaz-Miguel, J. Rosas, E. Raya, L. Carmona, L. Cea-Calvo, M.J. Arteaga, S. Fernández, C. Marras
CER9753
2017,35,3
Pg. 0431-0437
Free to view
Long-term treatment response in rheumatoid arthritis patients starting adalimumab or etanercept with or without concomitant methotrexate
M.J. L'ami, E.L. Kneepkens, M.T. Nurmohamed, C.L. Krieckaert, I.M. Visman, G.-J. Wolbink
M.J. L'ami, E.L. Kneepkens, M.T. Nurmohamed, C.L. Krieckaert, I.M. Visman, G.-J. Wolbink
CER9490
2017,35,3
Pg. 0438-0444
Free to view
Anti-La positive, anti-Ro negative subset of primary Sjögren’s syndrome: anti-La is a reality but is the disease?
D. Danda, R. Sharma, D. Truong, K.A. Koelsch, B.T. Kurien, H. Bagavant, U. Deshmukh, C.E. Kaufman, D.M. Lewis, D.U. Stone, L. Radfar, A. Rasmussen, K.L. Sivils, R.H. Scofield
D. Danda, R. Sharma, D. Truong, K.A. Koelsch, B.T. Kurien, H. Bagavant, U. Deshmukh, C.E. Kaufman, D.M. Lewis, D.U. Stone, L. Radfar, A. Rasmussen, K.L. Sivils, R.H. Scofield
CER9526
2017,35,3
Pg. 0445-0451
Free to view
Clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial
L. Coates, J.C. Packham, P. Creamer, S. Hailwood, A.S. Bhalla, K. Chakravarty, D. Mulherin, G. Taylor, D.L. Mattey, A.K. Bhalla
L. Coates, J.C. Packham, P. Creamer, S. Hailwood, A.S. Bhalla, K. Chakravarty, D. Mulherin, G. Taylor, D.L. Mattey, A.K. Bhalla
CER9645
2017,35,3
Pg. 0452-0461
Free to view
Zaocys type II collagen regulates the balance of Treg/Th17 cells in mice with collagen-induced arthritis
H. Wang, Z. Feng, J. Zhu, X. Chen, X. Wu, J. Li
H. Wang, Z. Feng, J. Zhu, X. Chen, X. Wu, J. Li
CER9874
2017,35,3
Pg. 0462-0470
Free to view
Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy?
H.G. Otten, W.J. Brummelhuis, R. Fritsch-Stork, H.L. Leavis, B.W. Wisse, J.M. Van Laar, R.H. Derksen
H.G. Otten, W.J. Brummelhuis, R. Fritsch-Stork, H.L. Leavis, B.W. Wisse, J.M. Van Laar, R.H. Derksen
CER9729
2017,35,3
Pg. 0471-0476
Free to view
Quantifying cutaneous adverse effects of systemic glucocorticoids in patients with rheumatoid arthritis: a cross-sectional cohort study
J. Amann, A.-M. Wessels, F. Breitenfeldt, D. Huscher, J.W. Bijlsma, J.W. Jacobs, F. Buttgereit
J. Amann, A.-M. Wessels, F. Breitenfeldt, D. Huscher, J.W. Bijlsma, J.W. Jacobs, F. Buttgereit
CER9985
2017,35,3
Pg. 0477-0483
Free to view
The spectrum of early rheumatoid arthritis practice across the globe: results from a multinational cross sectional survey
E. Nikiphorou, J. Galloway, P. Van Riel, Y. Yazici, G. Haugeberg, A. Ostor, F. Gogus, M. Kauppi, T. Sokka
on behalf of QUEST-RA
E. Nikiphorou, J. Galloway, P. Van Riel, Y. Yazici, G. Haugeberg, A. Ostor, F. Gogus, M. Kauppi, T. Sokka
on behalf of QUEST-RA
CER9841
2017,35,3
Pg. 0484-0493
Free to view
Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells
S. Soldano, S. Paolino, C. Pizzorni, A.C. Trombetta, P. Montagna, R. Brizzolara, C. Corallo, N. Giordano, A. Sulli, M. Cutolo
S. Soldano, S. Paolino, C. Pizzorni, A.C. Trombetta, P. Montagna, R. Brizzolara, C. Corallo, N. Giordano, A. Sulli, M. Cutolo
CER10148
2017,35,3
Pg. 0494-0499
Free to view
Good outcome of severe lupus patients with high-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation: a 10-year follow-up study
X.M. Leng, Y. Jiang, D.B. Zhou, X.P. Tian, T.S. Li, S.J. Wang, Y.Q. Zhao, T. Shen, X.F. Zeng, F.C. Zhang, F.L. Tang, Y. Dong, Y. Zhao
X.M. Leng, Y. Jiang, D.B. Zhou, X.P. Tian, T.S. Li, S.J. Wang, Y.Q. Zhao, T. Shen, X.F. Zeng, F.C. Zhang, F.L. Tang, Y. Dong, Y. Zhao
CER10121
2017,35,3
Pg. 0500-0507
Free to view
Autologous peripheral blood haematopoietic stem cell transplantation for systemic lupus erythematosus: the observation of long-term outcomes in a Chinese centre
C. Cao, M. Wang, J. Sun, X. Peng, Q. Liu, L. Huang, Y. Chai, K. Lai, P. Chen, Q. Liu, Q. Li, Y. Peng, H. Xiong, J. Zhang, M. Chen, K. Zeng
C. Cao, M. Wang, J. Sun, X. Peng, Q. Liu, L. Huang, Y. Chai, K. Lai, P. Chen, Q. Liu, Q. Li, Y. Peng, H. Xiong, J. Zhang, M. Chen, K. Zeng
Brief Papers
CER9606
2017,35,3
Pg. 0508-0511
Free to view
Which joints and why do rheumatologists scan in rheumatoid arthritis by ultrasonography? A real life experience
S.Z. Aydin, S. Pay, N. Inanc, S. Kamali, O. Karadag, P. Emery, M.-A. D'agostino
on behalf of the Targeted Ultrasound Initiative (TUI) Steering Committee
S.Z. Aydin, S. Pay, N. Inanc, S. Kamali, O. Karadag, P. Emery, M.-A. D'agostino
on behalf of the Targeted Ultrasound Initiative (TUI) Steering Committee
CER9633
2017,35,3
Pg. 0512-0515
Free to view
Use of biologic agents in idiopathic inflammatory myopathies in Sweden: a descriptive study of real life treatment
J. Svensson, M. Holmqvist, A. Tjärnlund, M. Dastmalchi, B. Hanna, S. Magnusson Bucher, I.E. Lundberg
J. Svensson, M. Holmqvist, A. Tjärnlund, M. Dastmalchi, B. Hanna, S. Magnusson Bucher, I.E. Lundberg
Case Reports
CER9895
2017,35,3
Pg. 0516-0517
Free to view
Critical role of STIR MRI in early detection of post-streptococcal periostitis with dysproteinaemia (Goldbloom’s syndrome)
R. Papa, A. Consolaro, F. Minoia, R. Caorsi, G. Magnano, M. Gattorno, A. Ravelli, P. Picco
R. Papa, A. Consolaro, F. Minoia, R. Caorsi, G. Magnano, M. Gattorno, A. Ravelli, P. Picco
Review
CER9598
2017,35,3
Pg. 0518-0526
Free to view
Do MicroRNAs have a key epigenetic role in osteoarthritis and in mechanotransduction?
A. De Palma, S. Cheleschi, N.A. Pascarelli, S. Tenti, M. Galeazzi, A. Fioravanti
A. De Palma, S. Cheleschi, N.A. Pascarelli, S. Tenti, M. Galeazzi, A. Fioravanti
CER9898
2017,35,3
Pg. 0527-0534
Free to view
Ultrasound of the osteoarthritic joint
A. Iagnocco, E. Naredo
A. Iagnocco, E. Naredo
Paediatric Rheumatology
CER9875
2017,35,3
Pg. 0535-0541
Free to view
Cardiovascular complications in paediatric-onset systemic lupus erythematosus in Saudi Arabian patients
A.S. Azhar, O.M. Awlia, M.A. Muzaffer
A.S. Azhar, O.M. Awlia, M.A. Muzaffer
Letters to the Editor
CER9683
2017,35,3
Pg. 0542
Free to view
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients
M. Sebastiani, A. Manfredi, G. Cassone, G. Sandri, S. Cerri, C. Ferri
M. Sebastiani, A. Manfredi, G. Cassone, G. Sandri, S. Cerri, C. Ferri
CER9842
2017,35,3
Pg. 0543
Free to view
Proangiogenic gene polymorphisms are associated with susceptibility to Paget's disease of bone and with its clinical features
I. Calero-Paniagua, R. Usategui-Martín, L. Corral-Gudino, J. García-Aparicio, J. Del pino-Montes, R. González-Sarmiento
I. Calero-Paniagua, R. Usategui-Martín, L. Corral-Gudino, J. García-Aparicio, J. Del pino-Montes, R. González-Sarmiento
CER10001
2017,35,3
Pg. 0544-0545
Free to view
Decreased antibodies against hepatitis A in previously vaccinated treatment naïve juvenile SLE patients: a prospective case control study
D.N. Maritsi, D. Eleftheriou, M. Onoufriou, G. Vartzelis
D.N. Maritsi, D. Eleftheriou, M. Onoufriou, G. Vartzelis
CER10092
2017,35,3
Pg. 0546-0547
Free to view
Correlation between ESSDAI and ClinESSDAI in a real-life cohort of patients with Sjögren’s syndrome
L. Quartuccio, C. Baldini, E. Bartoloni, R. Priori, F. Carubbi, A. Alunno, S. Gandolfo, A. Gattamelata, R. Giacomelli, R. Gerli, G. Valesini, S. Bombardieri, S. De Vita
GRISS Group (Gruppo di Ricerca Italiano sulla Sindrome di Sjögren)
L. Quartuccio, C. Baldini, E. Bartoloni, R. Priori, F. Carubbi, A. Alunno, S. Gandolfo, A. Gattamelata, R. Giacomelli, R. Gerli, G. Valesini, S. Bombardieri, S. De Vita
GRISS Group (Gruppo di Ricerca Italiano sulla Sindrome di Sjögren)
CER10299
2017,35,3
Pg. 0548
Free to view
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial
A. Giollo, D. Gatti, O. Viapiana, L. Idolazzi, A. Fassio, G. Adami, M. Rossini
A. Giollo, D. Gatti, O. Viapiana, L. Idolazzi, A. Fassio, G. Adami, M. Rossini
CER10348
2017,35,3
Pg. 0549
Free to view
Reply to comment on: Clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial
A.K. Bhalla, A.S. Bhalla, L.C. Coates, J.C. Packham, P. Creamer, S. Hailwood, K. Chakravarty, D. Mulherin, G. Taylor, D.L. Mattey
A.K. Bhalla, A.S. Bhalla, L.C. Coates, J.C. Packham, P. Creamer, S. Hailwood, K. Chakravarty, D. Mulherin, G. Taylor, D.L. Mattey
CER10005
2017,35,3
Pg. 0550
Free to view
Foot involvement in systemic lupus erythematosus: more than joint disease?
K. Rome, N. Dalbeth, P. Jarrett, S. Kumar, M. Carroll, A. Clendon, P. Gow
K. Rome, N. Dalbeth, P. Jarrett, S. Kumar, M. Carroll, A. Clendon, P. Gow